Efficacy of 1.25% amitraz solution in the treatment of generalized demodicosis (eight cases) and sarcoptic mange (five cases) in dogs.
Eight dogs with generalized demodicosis and five with sarcoptic manage were treated with 1.25% amitraz solution applied weekly and associated with an antidote treatment (atipamezol, 0.1 mg kg-1 i.m. once: and yohimbine 0.1 mg kg-1 once daily for 3 days, orally). Results of skin scrapings were used to determine whether therapy should be continued or stopped. The median number of treatments for demodicosis and sarcoptic mange was three (range 2-5) and two (range 1-3), respectively. Some side-effects were observed but all were stopped with antidote treatment; no failure or relapses occurred at 6-36 months after treatment.
Hugnet
C
C
Clinique vétérinaire des Lavandes, 26160 La Bégude de Mazenc, France.
Bruchon-Hugnet
C
C
Royer
H
H
Bourdoiseau
G
G
D000284:Administration, Oral; D000287:Administration, Topical; D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000977:Antiparasitic Agents; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use; D007273:Injections, Intramuscular / Q000662:veterinary; D007306:Insecticides / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D012532:Scabies / Q000188:drug therapy / Q000662:veterinary; D012876:Skin Diseases, Parasitic / Q000662:veterinary*; D014052:Toluidines / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome; D015016:Yohimbine / Q000008:administration & dosage / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000977:Antiparasitic Agents; D007093:Imidazoles; D007306:Insecticides; D014052:Toluidines; C050701:atipamezole; D015016:Yohimbine; C014983:amitraz